How should I evaluate and treat cadmium toxicity in a middle‑aged adult with possible occupational exposure presenting with proteinuria, reduced renal function, bone pain, and respiratory symptoms?

Cadmium Toxicity: Evaluation and Management

Immediate Action

Remove the patient from cadmium exposure immediately—this is the single most critical intervention, as cadmium has a biological half-life of 20-40 years and continued exposure will cause irreversible renal damage. 1

Diagnostic Evaluation

Blood and Urine Testing

• Measure blood cadmium levels to assess current body burden 2
• Obtain urinary cadmium concentration (adjusted for creatinine) to evaluate cumulative exposure 3
• Check serum creatinine and calculate glomerular filtration rate, as cadmium primarily damages renal tubules 1

Early Tubular Injury Markers

• Measure urinary β-2-microglobulin and N-acetyl-β-D-glucosaminidase (NAG) as sensitive early biomarkers of tubular injury—these detect damage before routine dipstick proteinuria becomes positive 1, 4
• Urinary β-2-microglobulin >34 µg/mmol creatinine indicates tubular proteinuria, though some experts use a lower threshold of 25 µg/mmol creatinine 3
• Standard urine dipstick testing will miss tubular proteinuria and should not be relied upon 4

Additional Assessment

• Monitor blood pressure, as cadmium exposure is linked to hypertension, particularly in women 1
• Evaluate for bone pain and consider bone mineral density testing if symptoms present, as cadmium causes bone demineralization in older adults (age >60) 2
• Screen for co-exposure to lead and other heavy metals, which compound renal toxicity 1

Risk Stratification

Patients with pre-existing hypertension or diabetes face dramatically increased susceptibility to cadmium-induced kidney damage and require more aggressive monitoring. 1

Dose-Response Relationships

• Urinary cadmium <1 nmol/mmol creatinine: 0.8% prevalence of tubular proteinuria 3
• Urinary cadmium 3 nmol/mmol creatinine: 10% prevalence of tubular proteinuria 3
• Urinary cadmium 15 nmol/mmol creatinine: 46-50% prevalence of tubular proteinuria 3
• The WHO limit of 10 nmol/mmol creatinine is too high; a threshold of 3 nmol/mmol creatinine is more appropriate 3

Age Considerations

• Patients >60 years show tubular proteinuria at lower urinary cadmium levels (1.5 nmol/mmol creatinine) compared to younger patients (5.0 nmol/mmol creatinine) 3
• Older patients have 3-fold increased risk of low bone mineral density at highest cadmium exposure levels 2

Treatment Approach

Primary Intervention

• Immediate and permanent removal from occupational exposure is the only effective treatment—there is no chelation therapy proven effective for cadmium toxicity 1
• Workers in battery manufacturing, metal working, welding, construction, and paint production are highest risk 1
• Inhalation of fumes and dust accounts for 10-50% absorption, with secondary ingestion through contaminated hands 1

Supportive Management

• Manage hypertension aggressively if present 1
• Provide renal-protective measures appropriate for chronic kidney disease stage 1
• Address bone health with calcium and vitamin D supplementation if bone disease present 2
• Counsel on smoking cessation, as cigarette smoke is a major non-occupational cadmium source 4, 5

Dietary Counseling

• For non-smokers without occupational exposure, diet is the only source 5
• Recommended tolerable intake is 60-70 µg per day 5
• Advise avoidance of foods from cadmium-contaminated soil and water 4

Long-Term Monitoring

Repeat renal function testing every 6-12 months initially, then annually if stable, due to cadmium's extremely long biological half-life of 20-40 years. 1

• Continue monitoring urinary β-2-microglobulin as the most sensitive marker 1
• Serial blood pressure checks given hypertension association 1
• Reassess for progression to clinical Fanconi syndrome (glycosuria, aminoaciduria, phosphaturia) with heavy exposure 4

Critical Pitfalls to Avoid

• Do not rely on routine urine dipstick testing—it will miss tubular proteinuria, which is the earliest and most sensitive manifestation of cadmium nephrotoxicity 4
• Do not use elevated urinary cadmium alone to assess body burden—it may reflect renal dysfunction rather than just high exposure 2
• Blood cadmium provides a more reliable dose estimate than urinary cadmium in patients with established renal dysfunction 2
• Recognize that continued exposure can progress from tubular proteinuria to Fanconi syndrome to end-stage renal failure 4
• Environmental cadmium exposure significantly contributes to chronic kidney disease development, especially with diabetes or hypertension comorbidities 4